Apollo Medical Holdings (NasdaqCM:AMEH) - Share price, News & Analysis

AMEH fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

AMEH Stock Overview

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services.

Rewards

Trading at 47.1% below our estimate of its fair value

Earnings grew by 59.6% over the past year

Risk Analysis

Large one-off items impacting financial results

Shareholders have been diluted in the past year

Apollo Medical Holdings Competitors

RadNet

NasdaqGM:RDNT

US$1.1b

Price History & Performance

Summary of all time highs, changes and price drops for Apollo Medical Holdings
Historical stock prices
Current Share Price	US$35.56
52 Week High	US$133.23
52 Week Low	US$29.52
Beta	0.56
1 Month Change	-7.35%
3 Month Change	-29.60%
1 Year Change	2.21%
3 Year Change	92.22%
5 Year Change	n/a
Change since IPO	228.04%

Recent News & Updates

May 17

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Shareholder Returns

	AMEH	US Healthcare	US Market
7D	2.2%	1.7%	1.0%
1Y	2.2%	1.8%	-15.1%

Return vs Industry: AMEH matched the US Healthcare industry which returned 1.8% over the past year.

Return vs Market: AMEH exceeded the US Market which returned -15.1% over the past year.

Price Volatility

Is AMEH's price volatile compared to industry and market?
AMEH volatility
AMEH Average Weekly Movement	11.5%
Healthcare Industry Average Movement	10.5%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	2.9%

Stable Share Price: AMEH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: AMEH's weekly volatility (11%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1994	1,133	Thomas Lam	https://www.apollomed.net

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Apollo Medical Holdings Fundamentals Summary

How do Apollo Medical Holdings's earnings and revenue compare to its market cap?
AMEH fundamental statistics
Market Cap	US$1.60b
Earnings (TTM)	US$74.97m
Revenue (TTM)	US$861.12m

21.4x

P/E Ratio

1.9x

P/S Ratio

Is AMEH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMEH income statement (TTM)
Revenue	US$861.12m
Cost of Revenue	US$676.26m
Gross Profit	US$184.86m
Other Expenses	US$109.89m
Earnings	US$74.97m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	1.66
Gross Margin	21.47%
Net Profit Margin	8.71%
Debt/Equity Ratio	34.8%

How did AMEH perform over the long term?

See historical performance and comparison

Valuation

Is Apollo Medical Holdings undervalued compared to its fair value and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

47.1%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: AMEH ($35.56) is trading below our estimate of fair value ($67.17)

Significantly Below Fair Value: AMEH is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: AMEH is poor value based on its Price-To-Earnings Ratio (21.4x) compared to the US Healthcare industry average (19.4x).

PE vs Market: AMEH is poor value based on its Price-To-Earnings Ratio (21.4x) compared to the US market (15.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AMEH's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: AMEH is overvalued based on its Price-To-Book Ratio (3.4x) compared to the US Healthcare industry average (2.5x).

Future Growth

How is Apollo Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

11.7%

Forecasted Healthcare industry annual growth in earnings

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AMEH's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if AMEH's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AMEH's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if AMEH's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AMEH's Return on Equity is forecast to be high in 3 years time

Past Performance

How has Apollo Medical Holdings performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

37.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AMEH has a large one-off loss of $33.1M impacting its March 31 2022 financial results.

Growing Profit Margin: AMEH's current net profit margins (8.7%) are higher than last year (6.7%).

Past Earnings Growth Analysis

Earnings Trend: AMEH's earnings have grown significantly by 37.6% per year over the past 5 years.

Accelerating Growth: AMEH's earnings growth over the past year (59.6%) exceeds its 5-year average (37.6% per year).

Earnings vs Industry: AMEH earnings growth over the past year (59.6%) exceeded the Healthcare industry 9.6%.

Return on Equity

High ROE: AMEH's Return on Equity (8.8%) is considered low.

Financial Health

How is Apollo Medical Holdings's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: AMEH's short term assets ($444.4M) exceed its short term liabilities ($160.4M).

Long Term Liabilities: AMEH's short term assets ($444.4M) exceed its long term liabilities ($220.2M).

Debt to Equity History and Analysis

Debt Level: AMEH has more cash than its total debt.

Reducing Debt: AMEH's debt to equity ratio has increased from 0% to 34.8% over the past 5 years.

Debt Coverage: AMEH's debt is well covered by operating cash flow (45.6%).

Interest Coverage: AMEH's interest payments on its debt are well covered by EBIT (28.6x coverage).

Balance Sheet

Dividend

What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate AMEH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMEH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMEH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMEH's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AMEH has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.5yrs

Average management tenure

CEO

Thomas Lam (72 yo)

2.67yrs

Tenure

US$6,857,194

Compensation

Dr. Thomas S. Lam, M.D., M.P.H., serves as President at Apollo Medical Holdings, Inc. since September 30, 2019. Dr. Lam is Co-Chief Executive Officer at Apollo Medical Holdings, Inc. since September 30, 20...

CEO Compensation Analysis

Compensation vs Market: Thomas's total compensation ($USD6.86M) is about average for companies of similar size in the US market ($USD5.40M).

Compensation vs Earnings: Thomas's compensation has increased by more than 20% in the past year.

Leadership Team

Experienced Management: AMEH's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.

Board Members

Experienced Board: AMEH's board of directors are considered experienced (4.2 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6%.

Data	Last Updated (UTC time)
Company Analysis	2022/05/26 00:00
End of Day Share Price	2022/05/26 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31